e.g. Tata motors, Reliance MF, 500570

Medicamen Biotech Ltd. - Research Center

531146 MEDICAMEQ Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 151.46 172.39 137.88 115.45 110.15
Expenses
Material consumed 82.75 91.38 71.82 52.62 67.42
Manufacturing expenses 5.60 0.08 13.56 12.94 9.20
Personnel expenses 21.57 22.12 18.57 14.50 8.79
Selling expenses 0.06 0.18 0.02 0.36 0.01
Adminstrative expenses 24.92 32.66 9.77 11.47 5.14
Expenses capitalised - - - - -
Cost of sales 134.91 146.42 113.74 91.89 90.57
Operating profit 16.56 25.97 24.15 23.56 19.58
Other recurring income 6.23 2.30 2.46 1.72 0.75
Adjusted PBDIT 22.78 28.27 26.61 25.28 20.33
Financial expenses 3.05 4.38 2.92 1.40 1.06
Depreciation 6.96 7.01 6.35 5.77 2.52
Other write offs - - - - -
Adjusted PBT 12.77 16.89 17.33 18.10 16.75
Tax charges 3.33 3.59 2.33 3.20 4.26
Adjusted PAT 9.45 13.30 15.00 14.91 12.49
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 9.45 13.30 15.00 14.91 12.49
Earnigs before appropriation 103.63 95.44 83.12 69.34 55.04
Equity dividend - 1.27 1.27 1.22 0.61
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 103.63 94.18 81.85 68.12 54.43
Close
Add Medicamen Biotech Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Medicamen Biotech Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback